<DOC>
	<DOC>NCT00328523</DOC>
	<brief_summary>In patients with primary hypercholesterolemia treated with a statin and with ldl-c above the recommended target goal (esc 2003 recommendations ldl&gt;=1.15 g/l) to compare the efficacy and the safety of ezetrol added to ongoing statin and non drug therapeutic intervention (patient motivation on diet or physical activities or both).</brief_summary>
	<brief_title>TWICE (Ezetimibe Together With Any Statin Cholesterol Enhancement)(0653-060)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Primary hypercholesterolemia treated with any statin at any dose, for at least 3 months with a ldl cholesterol above 115 mg/dl (esc 2003 recommendations). pregnant or breast feeding women Lipidlowering agents including hmgcoa reductase inhibitors other than the current statin, fish oils, cholestyramin, niacin (&gt;200 mg/day) and fibrates taken within the 3 months preceding visit 1.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>